Repligen Corp (NAS:RGEN)
$ 171.78 -0.16 (-0.09%) Market Cap: 9.60 Bil Enterprise Value: 9.56 Bil PE Ratio: 687.12 PB Ratio: 4.87 GF Score: 94/100

Repligen Corp at Stephens NASH Investment Conference (Virtual) Transcript

Nov 19, 2020 / 05:00PM GMT
Release Date Price: $187.29 (+0.99%)
Jacob K. Johnson
Stephens Inc., Research Division - Analyst

All right. Good morning. Unless you're on the East Coast, then I guess it's good afternoon. Welcome today for the Stephens conference. I'm Jacob Johnson, life science tools and diagnostics analyst. As always, very excited to be joined by Repligen. Today, we've got CEO, Tony Hunt; CFO, Jon Snodgres; Global Head of IR, Sondra Newman; and Manager of IR, Steve Chehames.

Before we get started, if you would like to submit a question during the presentation, there's a button on the top left of your screen where you could submit questions. You can also e-mail me at [email protected].

With that out of the way, Tony, maybe to kick things off, if you want to spend a couple of minutes giving us an update on all of the exciting things going on at Repligen right now.

Anthony J. Hunt
Repligen Corporation - CEO, President & Director

Yes. Thanks, Jacob. And maybe as a kickoff on this, obviously, everybody knows, and they've heard us, over the last few weeks, talk about our overall

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot